ERBB2 and breast carcinoma: Moreover, silencing of Blimp1 in N202-1A cells was sufficient to reduce cell invasion in vitro (Fig. 4C), further confirming that Blimp1 is critical for p130Cas/ErbB2-driven invasion in another cell model of breast cancer.